M
40
6
SBUX
39
3
GM
71
5
ILMN
61
-4
KHC
47
2
SE
61
4
MAR
68
3
TAP
61
8
HP
40
4
PPL
60
3
AVB
54
4
AMP
72
2
ETN
78
2
AAPL
46
-2
PNR
66
3
HCP
47
-2
GIS
31
2
V
62
10
BLK
75
2
PGR
63
5
M
40
6
SBUX
39
3
GM
71
5
ILMN
61
-4
KHC
47
2
SE
61
4
MAR
68
3
TAP
61
8
HP
40
4
PPL
60
3
AVB
54
4
AMP
72
2
ETN
78
2
AAPL
46
-2
PNR
66
3
HCP
47
-2
GIS
31
2
V
62
10
BLK
75
2
PGR
63
5
Financhill
Back

Apellis Pharmaceuticals Vs. Cytokinetics Industry Stock Comparison

Sell
34

APLS
Apellis Pharmaceuticals

Last Price:
27.90
Seasonality Move:
25.98%
Buy
52

CYTK
Cytokinetics

Last Price:
54.53
Seasonality Move:
11.98%
Sell
34
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $27.95. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Cytokinetics (CYTK) is a Buy

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $55.28. The Score for CYTK is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $27.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $55.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight selling pressure.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.21 Sell
Relative Strength Index (14 RSI): 34 Sell
Chaikin Money Flow: -61032 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.9 - 34.22) Sell
Bollinger Bands (100): (32.37 - 41.13) Sell

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 53.11 Buy
Chaikin Money Flow: -65602 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.87 - 55.81) Buy
Bollinger Bands (100): (52.18 - 57.16) Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.35 Buy
20-day SMA: 29.1 Sell
50-day SMA: 34.42 Sell
200-day SMA: 47.21 Sell
8-day EMA: 27.73 Buy
20-day EMA: 29.48 Sell
50-day EMA: 33.11 Sell
200-day EMA: 42.85 Sell

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.67 Buy
20-day SMA: 53.98 Buy
50-day SMA: 55.01 Buy
200-day SMA: 63.72 Sell
8-day EMA: 54.75 Buy
20-day EMA: 54.53 Buy
50-day EMA: 54.99 Buy
200-day EMA: 56.02 Sell

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.30 per share, and an increase next year of $1.30 per share.

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.28 per share, and an increase next year of $0.22 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):